文献速递骨肿瘤创伤骨科

骨盆肉瘤半骨盆切除术后的外科与肿瘤学结局

Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma.
PubMed 文献 · Bone Joint J · 2020-01-01

回顾性分析1996至2018年136例因骨盆肉瘤行半骨盆切除术的患者,骨肉瘤原发切除后总生存90.7个月,软组织肉瘤原发切除59.3个月而挽救性切除仅12.5个月。高组织学分级和软组织肉瘤诊断与不良预后相关,姑息性手术30天死亡率高达33.3%。

要点

  • 骨肉瘤原发与挽救性半骨盆切除总生存无差异,软组织肉瘤挽救性切除生存显著更差。
  • 高组织学分级和软组织肉瘤诊断是预后不良的独立因素。
  • 姑息性半骨盆切除30天死亡率高,需谨慎选择。

核心结论

  • 经过仔细选择的患者行半骨盆切除术可获得满意的总生存和较低的围手术期死亡风险,但并发症发生率较高。
  • 姑息性半骨盆切除术因早期术后死亡率高需谨慎考虑。

研究设计与样本

  • 回顾性 review,纳入1996至2018年在一家超区域肉瘤中心接受半骨盆切除术的所有肉瘤患者,共136例,平均年龄51岁(12至83岁),其中骨肉瘤91例,软组织肉瘤45例。

主要发现

  • 骨肉瘤原发半骨盆切除后总生存为90.7个月(95%CI 64.1至117.2),二次挽救性半骨盆切除为90.3个月(95%CI 58.1至122.5)(p=0.727)。
  • 软组织肉瘤原发半骨盆切除后总生存为59.3个月(95%CI 31.1至88.6),二次挽救性半骨盆切除为12.5个月(95%CI 9.4至15.5)(p=0.038)。
  • 多因素分析显示高组织学分级(HR 2.033,95%CI 1.127至3.676;p=0.018)和软组织肉瘤诊断(HR 1.653,95%CI 1.027至2.660;p=0.039)与不良预后相关。
  • 治愈性 intent 患者30天死亡率为0.8%(1/128),姑息性 intent 患者为33.3%(2/6)(p=0.001)。
  • 53.7%(n=73)的患者至少发生一种并发症,23.5%(n=32)需要至少一次再手术;直接闭合与皮瓣重建相比,完全一期伤口愈合率分别为60.0%(3/5)和82.0%(82/100)(p=0.023)。

临床怎么用

  • 对骨盆肉瘤患者行半骨盆切除术前应评估组织学分级和肿瘤类型,高分级和软组织肉瘤患者预后较差。
  • 姑息性半骨盆切除术因早期死亡率高,应严格掌握适应证。
  • 软组织肉瘤挽救性半骨盆切除术后生存极差,需充分告知患者。
  • 皮瓣重建可能优于直接闭合以提高伤口一期愈合率。

局限性

  • 回顾性 review,来自单中心超区域肉瘤单元,可能存在选择偏倚。
  • 姑息性手术样本量小(n=6),结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Survival rates and local control after resection of a sarcoma of the pelvis compare poorly to those of the limbs and have a high incidence of complications. The outcome for patients who need a hindquarter amputation (HQA) to treat a pelvic sarcoma is poor. Our aim was to evaluate the patient, tumour, and reconstructive factors that affect the survival of the patients who undergo HQA for primary or recurrent pelvic sarcoma. METHODS: We carried out a retrospective review of all sarcoma patients who had undergone a HQA in a supraregional sarcoma unit between 1996 and 2018. Outcomes included oncological, surgical, and survival characteristics. RESULTS: A total of 136 patients, with a mean age of 51 (12 to 83) underwent HQA, 91 for a bone sarcoma and 45 for a soft tissue sarcoma. The overall survival (OS) after primary HQA for a bone sarcoma was 90.7 months (95% confidence interval (CI) 64.1 to 117.2). In patients undergoing a secondary salvage HQA it was 90.3 months (95% CI 58.1 to 122.5) (p = 0.727). For those treated for a soft tissue sarcoma (STS), the mean OS was 59.3 months (95% CI 31.1 to 88.6) for patients with a primary HQA, and 12.5 months (95% CI 9.4 to 15.5) for those undergoing a secondary salvage HQA (p = 0.038). On multivariate analysis, high histological grade (hazard ratio (HR) 2.033, 95% CI 1.127 to 3.676; p = 0.018) and a diagnosis of STS (HR 1.653, 95% CI 1.027 to 2.660; p = 0.039) were associated with a poor prognosis. The 30-day mortality for patients with curative intent was 0.8% (1/128). For those in whom surgery was carried out with palliative intent it was 33.3% (2/6) (p = 0.001). In total, 53.7% (n = 73) of patients had at least one complication with 23.5% (n = 32) requiring at least one further operation. Direct closure was inferior to flap reconstruction in terms of complete primary wound healing (60.0% (3/5) vs 82.0% (82/100); p = 0.023). CONCLUSION: In carefully selected patients HQA is associated with satisfactory overall survival, with a low risk of perioperative mortality, but considerable morbidity. However, caution must be exercised when considering the procedure for palliation due to the high incidence of early postoperative mortality. Cite this article: Bone Joint J 2020;102-B(6):788-794.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Kiiski J, Parry MC, Le Nail LR, et al. Surgical and oncological outcomes after hindquarter amputation for pelvic sarcoma. Bone Joint J. 2020. PMID: 32475235. doi:10.1302/0301-620X.102B6.BJJ-2019-1317.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。